IBDEI0JZ ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,8989,1,4,0)
;;=4^K71.3
;;^UTILITY(U,$J,358.3,8989,2)
;;=^5008797
;;^UTILITY(U,$J,358.3,8990,0)
;;=K71.4^^39^404^29
;;^UTILITY(U,$J,358.3,8990,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8990,1,3,0)
;;=3^Toxic Liver Disease w/ Chronic Lobular Hepatitis
;;^UTILITY(U,$J,358.3,8990,1,4,0)
;;=4^K71.4
;;^UTILITY(U,$J,358.3,8990,2)
;;=^5008798
;;^UTILITY(U,$J,358.3,8991,0)
;;=K75.81^^39^404^21
;;^UTILITY(U,$J,358.3,8991,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8991,1,3,0)
;;=3^Nonalcoholic Steatohepatitis (NASH)
;;^UTILITY(U,$J,358.3,8991,1,4,0)
;;=4^K75.81
;;^UTILITY(U,$J,358.3,8991,2)
;;=^5008828
;;^UTILITY(U,$J,358.3,8992,0)
;;=K75.89^^39^404^18
;;^UTILITY(U,$J,358.3,8992,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8992,1,3,0)
;;=3^Inflammatory Liver Disease,Oth Spec
;;^UTILITY(U,$J,358.3,8992,1,4,0)
;;=4^K75.89
;;^UTILITY(U,$J,358.3,8992,2)
;;=^5008829
;;^UTILITY(U,$J,358.3,8993,0)
;;=K76.4^^39^404^23
;;^UTILITY(U,$J,358.3,8993,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8993,1,3,0)
;;=3^Peliosis Hepatis
;;^UTILITY(U,$J,358.3,8993,1,4,0)
;;=4^K76.4
;;^UTILITY(U,$J,358.3,8993,2)
;;=^91041
;;^UTILITY(U,$J,358.3,8994,0)
;;=K71.50^^39^404^27
;;^UTILITY(U,$J,358.3,8994,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8994,1,3,0)
;;=3^Toxic Liver Disease w/ Chronic Active Hepatitis w/o Ascites
;;^UTILITY(U,$J,358.3,8994,1,4,0)
;;=4^K71.50
;;^UTILITY(U,$J,358.3,8994,2)
;;=^5008799
;;^UTILITY(U,$J,358.3,8995,0)
;;=K71.51^^39^404^28
;;^UTILITY(U,$J,358.3,8995,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8995,1,3,0)
;;=3^Toxic Liver Disease w/ Chronic Active Hepatitis w/ Ascites
;;^UTILITY(U,$J,358.3,8995,1,4,0)
;;=4^K71.51
;;^UTILITY(U,$J,358.3,8995,2)
;;=^5008800
;;^UTILITY(U,$J,358.3,8996,0)
;;=K71.7^^39^404^31
;;^UTILITY(U,$J,358.3,8996,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8996,1,3,0)
;;=3^Toxic Liver Disease w/ Fibrosis & Cirrhosis of Liver
;;^UTILITY(U,$J,358.3,8996,1,4,0)
;;=4^K71.7
;;^UTILITY(U,$J,358.3,8996,2)
;;=^5008802
;;^UTILITY(U,$J,358.3,8997,0)
;;=K71.8^^39^404^35
;;^UTILITY(U,$J,358.3,8997,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8997,1,3,0)
;;=3^Toxic Liver Disease w/ Oth Disorders of Liver
;;^UTILITY(U,$J,358.3,8997,1,4,0)
;;=4^K71.8
;;^UTILITY(U,$J,358.3,8997,2)
;;=^5008803
;;^UTILITY(U,$J,358.3,8998,0)
;;=K71.9^^39^404^36
;;^UTILITY(U,$J,358.3,8998,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8998,1,3,0)
;;=3^Toxic Liver Disease,Unspec
;;^UTILITY(U,$J,358.3,8998,1,4,0)
;;=4^K71.9
;;^UTILITY(U,$J,358.3,8998,2)
;;=^5008804
;;^UTILITY(U,$J,358.3,8999,0)
;;=K75.2^^39^404^22
;;^UTILITY(U,$J,358.3,8999,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8999,1,3,0)
;;=3^Nonspecific Reactive Hepatitis
;;^UTILITY(U,$J,358.3,8999,1,4,0)
;;=4^K75.2
;;^UTILITY(U,$J,358.3,8999,2)
;;=^5008826
;;^UTILITY(U,$J,358.3,9000,0)
;;=K75.3^^39^404^13
;;^UTILITY(U,$J,358.3,9000,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,9000,1,3,0)
;;=3^Granulomatous Hepatitis NEC
;;^UTILITY(U,$J,358.3,9000,1,4,0)
;;=4^K75.3
;;^UTILITY(U,$J,358.3,9000,2)
;;=^5008827
;;^UTILITY(U,$J,358.3,9001,0)
;;=K76.6^^39^404^24
;;^UTILITY(U,$J,358.3,9001,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,9001,1,3,0)
;;=3^Portal Hypertension
;;^UTILITY(U,$J,358.3,9001,1,4,0)
;;=4^K76.6
;;^UTILITY(U,$J,358.3,9001,2)
;;=^5008834
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0JZ 3759 printed Dec 13, 2024@01:50:10 Page 2
IBDEI0JZ ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,8989,1,4,0)
+2 ;;=4^K71.3
+3 ;;^UTILITY(U,$J,358.3,8989,2)
+4 ;;=^5008797
+5 ;;^UTILITY(U,$J,358.3,8990,0)
+6 ;;=K71.4^^39^404^29
+7 ;;^UTILITY(U,$J,358.3,8990,1,0)
+8 ;;=^358.31IA^4^2
+9 ;;^UTILITY(U,$J,358.3,8990,1,3,0)
+10 ;;=3^Toxic Liver Disease w/ Chronic Lobular Hepatitis
+11 ;;^UTILITY(U,$J,358.3,8990,1,4,0)
+12 ;;=4^K71.4
+13 ;;^UTILITY(U,$J,358.3,8990,2)
+14 ;;=^5008798
+15 ;;^UTILITY(U,$J,358.3,8991,0)
+16 ;;=K75.81^^39^404^21
+17 ;;^UTILITY(U,$J,358.3,8991,1,0)
+18 ;;=^358.31IA^4^2
+19 ;;^UTILITY(U,$J,358.3,8991,1,3,0)
+20 ;;=3^Nonalcoholic Steatohepatitis (NASH)
+21 ;;^UTILITY(U,$J,358.3,8991,1,4,0)
+22 ;;=4^K75.81
+23 ;;^UTILITY(U,$J,358.3,8991,2)
+24 ;;=^5008828
+25 ;;^UTILITY(U,$J,358.3,8992,0)
+26 ;;=K75.89^^39^404^18
+27 ;;^UTILITY(U,$J,358.3,8992,1,0)
+28 ;;=^358.31IA^4^2
+29 ;;^UTILITY(U,$J,358.3,8992,1,3,0)
+30 ;;=3^Inflammatory Liver Disease,Oth Spec
+31 ;;^UTILITY(U,$J,358.3,8992,1,4,0)
+32 ;;=4^K75.89
+33 ;;^UTILITY(U,$J,358.3,8992,2)
+34 ;;=^5008829
+35 ;;^UTILITY(U,$J,358.3,8993,0)
+36 ;;=K76.4^^39^404^23
+37 ;;^UTILITY(U,$J,358.3,8993,1,0)
+38 ;;=^358.31IA^4^2
+39 ;;^UTILITY(U,$J,358.3,8993,1,3,0)
+40 ;;=3^Peliosis Hepatis
+41 ;;^UTILITY(U,$J,358.3,8993,1,4,0)
+42 ;;=4^K76.4
+43 ;;^UTILITY(U,$J,358.3,8993,2)
+44 ;;=^91041
+45 ;;^UTILITY(U,$J,358.3,8994,0)
+46 ;;=K71.50^^39^404^27
+47 ;;^UTILITY(U,$J,358.3,8994,1,0)
+48 ;;=^358.31IA^4^2
+49 ;;^UTILITY(U,$J,358.3,8994,1,3,0)
+50 ;;=3^Toxic Liver Disease w/ Chronic Active Hepatitis w/o Ascites
+51 ;;^UTILITY(U,$J,358.3,8994,1,4,0)
+52 ;;=4^K71.50
+53 ;;^UTILITY(U,$J,358.3,8994,2)
+54 ;;=^5008799
+55 ;;^UTILITY(U,$J,358.3,8995,0)
+56 ;;=K71.51^^39^404^28
+57 ;;^UTILITY(U,$J,358.3,8995,1,0)
+58 ;;=^358.31IA^4^2
+59 ;;^UTILITY(U,$J,358.3,8995,1,3,0)
+60 ;;=3^Toxic Liver Disease w/ Chronic Active Hepatitis w/ Ascites
+61 ;;^UTILITY(U,$J,358.3,8995,1,4,0)
+62 ;;=4^K71.51
+63 ;;^UTILITY(U,$J,358.3,8995,2)
+64 ;;=^5008800
+65 ;;^UTILITY(U,$J,358.3,8996,0)
+66 ;;=K71.7^^39^404^31
+67 ;;^UTILITY(U,$J,358.3,8996,1,0)
+68 ;;=^358.31IA^4^2
+69 ;;^UTILITY(U,$J,358.3,8996,1,3,0)
+70 ;;=3^Toxic Liver Disease w/ Fibrosis & Cirrhosis of Liver
+71 ;;^UTILITY(U,$J,358.3,8996,1,4,0)
+72 ;;=4^K71.7
+73 ;;^UTILITY(U,$J,358.3,8996,2)
+74 ;;=^5008802
+75 ;;^UTILITY(U,$J,358.3,8997,0)
+76 ;;=K71.8^^39^404^35
+77 ;;^UTILITY(U,$J,358.3,8997,1,0)
+78 ;;=^358.31IA^4^2
+79 ;;^UTILITY(U,$J,358.3,8997,1,3,0)
+80 ;;=3^Toxic Liver Disease w/ Oth Disorders of Liver
+81 ;;^UTILITY(U,$J,358.3,8997,1,4,0)
+82 ;;=4^K71.8
+83 ;;^UTILITY(U,$J,358.3,8997,2)
+84 ;;=^5008803
+85 ;;^UTILITY(U,$J,358.3,8998,0)
+86 ;;=K71.9^^39^404^36
+87 ;;^UTILITY(U,$J,358.3,8998,1,0)
+88 ;;=^358.31IA^4^2
+89 ;;^UTILITY(U,$J,358.3,8998,1,3,0)
+90 ;;=3^Toxic Liver Disease,Unspec
+91 ;;^UTILITY(U,$J,358.3,8998,1,4,0)
+92 ;;=4^K71.9
+93 ;;^UTILITY(U,$J,358.3,8998,2)
+94 ;;=^5008804
+95 ;;^UTILITY(U,$J,358.3,8999,0)
+96 ;;=K75.2^^39^404^22
+97 ;;^UTILITY(U,$J,358.3,8999,1,0)
+98 ;;=^358.31IA^4^2
+99 ;;^UTILITY(U,$J,358.3,8999,1,3,0)
+100 ;;=3^Nonspecific Reactive Hepatitis
+101 ;;^UTILITY(U,$J,358.3,8999,1,4,0)
+102 ;;=4^K75.2
+103 ;;^UTILITY(U,$J,358.3,8999,2)
+104 ;;=^5008826
+105 ;;^UTILITY(U,$J,358.3,9000,0)
+106 ;;=K75.3^^39^404^13
+107 ;;^UTILITY(U,$J,358.3,9000,1,0)
+108 ;;=^358.31IA^4^2
+109 ;;^UTILITY(U,$J,358.3,9000,1,3,0)
+110 ;;=3^Granulomatous Hepatitis NEC
+111 ;;^UTILITY(U,$J,358.3,9000,1,4,0)
+112 ;;=4^K75.3
+113 ;;^UTILITY(U,$J,358.3,9000,2)
+114 ;;=^5008827
+115 ;;^UTILITY(U,$J,358.3,9001,0)
+116 ;;=K76.6^^39^404^24
+117 ;;^UTILITY(U,$J,358.3,9001,1,0)
+118 ;;=^358.31IA^4^2
+119 ;;^UTILITY(U,$J,358.3,9001,1,3,0)
+120 ;;=3^Portal Hypertension
+121 ;;^UTILITY(U,$J,358.3,9001,1,4,0)
+122 ;;=4^K76.6
+123 ;;^UTILITY(U,$J,358.3,9001,2)
+124 ;;=^5008834
